September 2015 | Gotoper.com

Current Issue

Chairman's Letter

From The Editor

From the Editor

Hepatocellular Carcinoma

New Therapies and Potential Biomarkers for Hepatocellular Carcinoma

Renal Cell Carcinoma

Clinical Commentary: The Use of Clinical Biomarkers to Inform Treatment Decisions in Advanced Renal Cell Carcinoma

Multiple Myeloma

Genomic Landscape and Mechanisms of Disease Evolution and Progression in Multiple Myeloma

Prostate Cancer

An Integrative Approach for Sequencing Therapies in Metastatic Prostate Cancer

Lung Cancer

RET-Rearranged Lung Cancer

CME

Oncology Briefings™: Integrating Novel Targeted Treatment Strategies to Advance Pancreatic Cancer Care

Oncology Briefings™: New Frontiers in the Treatment of MSI High Endometrial Cancer

Considerations and Advancements of Precision Medicine in GI Cancers

Archive

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

May 2017

April 2017

March 2017

February 2017

January 2017

December 2016

November 2016

October 2016

September 2016

August 2016

July 2016

June 2016

May 2016

April 2016

March 2016

February 2016

January 2016

December 2015

November 2015

October 2015

September 2015

August 2015

July 2015

June 2015

May 2015

April 2015

March 2015

February 2015

January 2015

December 2014

November 2014

September 2014

August 2014

CME-Certified Activities From PER®

Author Instructions

Issue List

September 2015

Chairman's Note

Michael J. Hennessy

From the Editor

Debu Tripathy, MD

Immunotherapy

Breast Cancer Immunotherapy: Is It Ready for Prime Time?

Elizabeth A. Mittendorf, MD, PhD; Kelly K. Hunt, MD

PD-1 and PD-L1 Inhibitors: Activity as Single Agents and Potential Biomarkers in Non-Small Cell Lung Cancer

Sarah B. Goldberg, MD

NSCLC

Antiangiogenesis and Future Combinations with Anti-Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer

Edward S. Kim, MD

Prostate Cancer

Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer?

Bobby C. Liaw, MD; William K. Oh, MD

Clinical Controversies

Putting the "Great Mammography Debate" to Rest

Carlie K. Thompson, MD; Martin Eklund, PhD; Laura J. Esserman, MD, MBA

SUN	MON	TUES	WED	THURS	FRI	SAT
					1 ASCO: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your Patients June 1, 2018 Chicago, IL CME 2.0 ASCO: Medical Crossfire®: The Advent of CAR T-Cell Therapy for Lymphoid Malignancies and Beyond June 1, 2018 Chicago, IL CME 2.0 ASCO: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary Cancers June 1, 2018 Chicago, IL CME 2.0	2 ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy June 2, 2018 Chicago, IL CME 2.0 ASCO: Matching Treatment to Patient in an Ever-Changing Era for the Management of Advanced Renal Cell Carcinoma: An Expert Tumor Board Discussion June 2, 2018 Chicago, IL CME 2.0
3 ASCO: Medical Crossfire®: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid Foundation June 3, 2018 Chicago, IL CME 2.0 ASCO: Navigating New Sequencing Challenges for the Treatment of Hepatocellular Carcinoma June 3, 2018 Chicago, IL CME 2.0 ASCO: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting June 3, 2018 Chicago, IL CME 1.5	4	5	6	7	8	9
10	11	12	13	14	15 Community Practice Connections™: Oncology Best Practice™ Optimizing Outcomes When Quality Is Being Measured: A Focus on Evidence-Based Care for Gastric and Gastroesophageal Junction Cancer Treatment Expires on Jun 15, 2018 CME 2.0	16
17	18	19	20	21	22	23 2nd Annual International Congress on Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards June 23, 2018 New York, NY CME 7.25
24	25	26	27	28	29	30 Oncology Briefings™: Overcoming Chronic Iron Overload in Pediatric AML and MDS Expires on Jun 30, 2018 CME 1.0 Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient Care Expires on Jun 30, 2018 CME 1.5 Community Practice Connections™: 2nd Annual School of Gastrointestinal Oncology™ Expires on Jun 30, 2018 CME 1.5 Community Practice Connections™: 4th Annual Miami Lung Cancer Conference® Expires on Jun 30, 2018 CME 7.0